Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Learn how to plan for success using zero based budgeting to achieve your financial goals. Start your journey to success today.
19,670 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
This in-depth guide breaks down Employers EIG 2025 earnings, focusing on Q4 results, guidance, and what it means for ...
FedEx says it will return tariff refunds to customers who paid them after a Supreme Court ruling curbed IEEPA tariffs...
REX Shares launches a new wave of ETF products focused on income, leverage, crypto, and thematic strategies to meet d...
This guide unpacks Granite Ridge earnings in plain terms. Learn the key metrics, what to listen for in the GRNT earni...
A new ETF focused on CTAs began trading this week, giving U.S. investors direct exposure to trend-following across mu...
Small-cap value stocks offer a different path to growth and income. This guide compares ISCV and VBR to help you deci...
A private liberal arts college in the Pacific Northwest launches a four-year tuition cap set at 10% of a family’s inc...
Natural gas prices push higher, renewing interest in AMLP. Retirees weigh the fund’s 7.6% yield and rising distributi...
As investors eye StepStone's Q4 2026 earnings, understanding revenue mix, margin dynamics, and guidance becomes essen...
SpaceX is positioning Starship V3 as the backbone of an IPO that could redefine private markets. Analysts say the nex...
SpaceX is entering the IPO spotlight, but valuing a space, AI, and satellite powerhouse is unique. This guide breaks ...